Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin for MRSA cSSTI
NCT00463801Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jan 2007
- Primary completion
- Nov 2007
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in Skin and Skin Structure Infection (SSSI), sponsored by Novartis. Started Jan 2007; status: terminated.
02
Drugs
daptomycin
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00463801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463801.